Geraldine McFarlane - Concepedia

Author

Geraldine McFarlane

Princeton University

Also Known As

Geraldine McFarlane, Geraldine R. McFarlane

Publications

333

Citations

H-Index

Concepts

All Affiliations

Princeton University

About

Geraldine McFarlane is an author at Princeton University specializing in pharmacology, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	296
2	Natural Sciences	2	2	211
3	Biochemistry	2	2	211
4	Social Sciences	1	1	18
5	Biomedical Engineering	1	1	53

Geraldine McFarlane

Publications

326

Citations

H-Index

Page 1

	Year	Citations
Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization Hassan Elokdah, Magid Abou‐Gharbia, James K. Hennan, Journal of Medicinal Chemistry Pharmaceutical ScienceAntiparasitic AgentCardiovascular PharmacologyPharmacotherapyPharmaceutical Chemistry	2004	166
Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 2. Selective and Potent Benzylamino Cyclobutenediones A. Gilbert, Madelene Antane, Thomas M. Argentieri, Journal of Medicinal Chemistry Vitro PotencyPotassium Channel OpenersMedicinal ChemistryMedicinePhysiology	2000	53
Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties Hassan Elokdah, Theodore S. Sulkowski, Magid Abou‐Gharbia, Journal of Medicinal Chemistry Substituted SulfanyldihydroimidazolonesPharmaceutical SciencePharmacotherapyCompound 2.39Pharmaceutical Chemistry	2003	45
Regioselective Suzuki coupling of benzofuran or benzothiophene boronic acids and dibromo substituted naphthalenes: synthesis of a potent inhibitor of plasminogen activator inhibitor-1 Zheng Wang, Hassan Elokdah, Geraldine McFarlane, Tetrahedron Letters Medicinal ChemistryRegioselective Suzuki CouplingPlasminogen Activator Inhibitor-1PharmacologyBenzothiophene Boronic Acids	2006	30
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia David P. Rotella, Geraldine McFarlane, Alexander Greenfield, Bioorganic & Medicinal Chemistry Letters Psychoactive DrugPsychiatryPsychotic DisorderMedicinePsychopharmacology	2009	18
Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists Hassan Elokdah, David Li, Geraldine McFarlane, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryMedicine5-Ht6 AgonistsPharmacological Agent	2007	14

Page 1